Patients with cancer or suspected cancer who have interstitial lung lesions
Conditions
Interventions
None listed
Sponsors
Hamamatsu University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who meet all of the following criteria will be enrolled: 1. Patients with a diagnosis or clinical suspicion of cancer. 2. Patients with findings on chest CT that suggest lung fibrosis. 3. Patients who are scheduled for or undergoing treatment for cancer (surgery, radiation, or drug therapy). 4. Patients who have given their consent to participate in this study by signing a consent form in person. 5. 5. 18 years old or older
Exclusion criteria
Exclusion criteria: Patients with any of the following will not be included in the study: 1. patients with no diagnosis or clinical suspicion of cancer 2. patients with no evidence of fibrosis on chest CT 3. patients who are not scheduled for treatment for cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cumulative incidence of lung injury: The cumulative incidence of lung injury is determined by the Gray test, from the date of enrollment to the occurrence of lung injury. Death from any cause is treated as a competing risk. | — |
Secondary
| Measure | Time frame |
|---|---|
| Analysis of risk factors for lung injury: obtained by univariate and multivariate Fine-Gray tests. Analysis of risk factors for lung injury by cancer treatment | — |
Countries
Japan
Contacts
Public ContactMasato Karayama
Hamamatsu University School of Medicine Cancer Center
Outcome results
None listed